Literature DB >> 26994376

Improving global vaccine accessibility.

Andrew B Hill1, Christopher Kilgore1, Margaret McGlynn1, Charles H Jones2.   

Abstract

Although the beneficial impact of vaccination is well established, developing countries often rely upon humanitarian support to obtain access to routine immunization schedules. Furthermore, philanthropic funders require that vaccines be supplied at prices that are drastically lower than that charged in developed nations. This pricing requirement arises due to both the massive volume of vaccines needed and the logistics necessary to ensure their integrity (i.e. the cold chain). Cost-prohibitive vaccine formulation strategies, especially for newer vaccines, along with the lack of infrastructure in developing nations can further complicate this process. Extensive research is being conducted to develop novel technological platforms that overcome each of these accessibility impediments. This review provides an overview of the humanitarian organizations and technological developments that are dedicated to improving global healthcare by increasing vaccine accessibility. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 26994376     DOI: 10.1016/j.copbio.2016.03.002

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  8 in total

1.  Desiccation-tolerance and globular proteins adsorb similar amounts of water.

Authors:  Julia A Brom; Gary J Pielak
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

2.  Protection by desiccation-tolerance proteins probed at the residue level.

Authors:  Candice J Crilly; Julia A Brom; Owen Warmuth; Harrison J Esterly; Gary J Pielak
Journal:  Protein Sci       Date:  2021-11-24       Impact factor: 6.725

3.  Dried Protein Structure Revealed at the Residue Level by Liquid-Observed Vapor Exchange NMR.

Authors:  Candice J Crilly; Julia A Brom; Mark E Kowalewski; Samantha Piszkiewicz; Gary J Pielak
Journal:  Biochemistry       Date:  2021-01-05       Impact factor: 3.162

4.  Escherichia coli-derived virus-like particles in vaccine development.

Authors:  Xiaofen Huang; Xin Wang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  NPJ Vaccines       Date:  2017-02-09       Impact factor: 7.344

5.  Lyophilized yeast powder for adjuvant free thermostable vaccine delivery.

Authors:  Ravinder Kumar; Bhushan N Kharbikar
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-09       Impact factor: 4.813

6.  Cold Chain Management by Healthcare Providers at a District in Ghana: A Mixed Methods Study.

Authors:  Anthoniette Asamoah; Nancy Innocentia Ebu Enyan; Abigail Kusi-Amponsah Diji; Charles Domfeh
Journal:  Biomed Res Int       Date:  2021-09-13       Impact factor: 3.411

7.  Multi-Omics Approach Reveals the Potential Core Vaccine Targets for the Emerging Foodborne Pathogen Campylobacter jejuni.

Authors:  Hengchun Cao; Hanxiao Xu; Chunhui Ning; Li Xiang; Qiufang Ren; Tiantian Zhang; Yusen Zhang; Rui Gao
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

8.  The Outer Membrane Vesicles of Salmonella enterica Serovar Typhimurium Activate Chicken Immune Cells through Lipopolysaccharides and Membrane Proteins.

Authors:  Hongxiao Cui; Yajun Sun; Hua Lin; Yan Zhao; Xin Zhao
Journal:  Pathogens       Date:  2022-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.